Distinguishing Acute Kidney Injury from Chronic Kidney Disease

Diagnostic Approach

For a patient with unknown baseline creatinine, estimate baseline creatinine by back-calculating from an assumed eGFR of 75 ml/min/1.73 m², which helps determine if AKI criteria are met, according to Praxis Medical Insights 1
Recent acute illness, sepsis, hypotension, or nephrotoxin exposure within the past 7-90 days favors AKI 1
Normal to enlarged kidney size on ultrasound with preserved parenchymal thickness also favors AKI 1
The presence of small kidneys (<9 cm) with reduced cortical thickness on ultrasound favors CKD 1
Anemia, hyperparathyroidism, or metabolic bone disease favors CKD 1
Long-standing hypertension or previously documented proteinuria favors CKD 1

The American Journal of Kidney Diseases recommends avoiding metformin completely in patients with creatinine ≥1.5 mg/dL in men or ≥1.4 mg/dL in women due to lactic acidosis risk 4, 5
Glipizide is the preferred second-generation sulfonylurea because it has no active metabolites and does not increase hypoglycemia risk in renal impairment, as stated by the American Journal of Kidney Diseases 4, 5
Repaglinide does not accumulate with decreased kidney function and can be started with 0.5 mg with each meal when eGFR <30 ml/min/1.73 m², according to the American Journal of Kidney Diseases 4, 5

Patients with decreased kidney function have dramatically increased hypoglycemia risk due to decreased clearance of insulin and oral agents, and impaired renal gluconeogenesis, as reported by the American Journal of Kidney Diseases 4, 5
Patients must monitor glucose levels closely and reduce medication doses as needed to minimize hypoglycemia risk, according to the American Journal of Kidney Diseases 4, 5
Target HbA1c of 7.0% rather than more intensive goals to reduce hypoglycemia risk, as recommended by the American Journal of Kidney Diseases 5

Plan nephrology follow-up within 7-14 days regardless of presumed diagnosis, and monitor kidney function for at least 90 days to distinguish AKD from CKD progression, as suggested by Praxis Medical Insights 1
Repeat creatinine every 48-72 hours initially to establish trajectory, and continue monitoring for 90 days minimum, according to Praxis Medical Insights 1